Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Rev. bras. cir. cardiovasc ; 37(3): 281-291, May-June 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1376534

ABSTRACT

ABSTRACT Introduction: Pediatric heart transplantation is the definitive therapy for children with end-stage heart failure. This paper describes our initial experience in pediatric heart transplantation in a tertiary center in Brazil Methods: This is a historical prospective descriptive cohort study based on a review of the medical records of children undergoing heart transplantation at Hospital de Base and Hospital da Criança e Maternidade de São José do Rio Preto. Variables were displayed as frequency, mean, or median. Statistical analysis and Kaplan-Meier actuarial curve were obtained with the aid of Microsoft® Excel® 2019 and STATSDirect version 3.3.5. Results: Between January 2010 and December 2020, ten children underwent bicaval orthotopic heart transplantation, 30% of which were under one year of age. Nine patients had end-stage heart failure (International Society for Heart and Lung Transplantation-Heart Failure D) and 50% of the recipients were transplanted under conditions of progressive clinical deterioration (Interagency Registry for Mechanically Assisted Circulatory Support ≤ 2). Forty percent of the recipients had a panel-reactive antibody > 20% on virtual crossmatch. In the postoperative period, 80% of patients required high dose of inotropic support (vasoactive-inotropic score > 10) for > 48 hours. The death-free survival rate at 131 months was 77.1±14.4%. Most patients (88.9%) in late follow-up had an episode of active cytomegalovirus infection. Cellular rejection, with or without clinical repercussion, was present in 44.4% of the patients. Conclusion: Pediatric heart transplantation produces acceptable and feasible outcomes as definitive therapy for children with end-stage heart failure.

2.
Rev. bras. cardiol. invasiva ; 18(4): 435-442, dez. 2010. ilus, tab, graf
Article in Portuguese | LILACS | ID: lil-582211

ABSTRACT

INTRODÇÃO: A introdução da cirurgia de anastomose cavopulmonar total (ACPT) ou cirurgia de Fontan modificou de forma significativa a história natural de pacientes com cardiopatias complexas não passíveis de reparo biventricular. Entretanto, é conhecido o desenvolvimento de estenoses silenciosas. Além disso, a utilização de condutos fenestrados é uma técnica comumente realizada, O presente estudo relata a experiência de um centro terciário no implante pecutâneo de dispositivos em condutos de pacientes com circulação do tipo univentricular. Método: Entre julho de 2000 e julho de 2010, 12 pacientes receberam dispositivos percutâneos em condutos após cirurgia de Fontan. Os pacientes foram divididos em dois grupos de acordo com a indicação para o procedimento: 5 pacientes receberam implante de oclusores septais para fechamento de fenestração cirurgia (grupo 1), 6 pacientes receberam stents para alívio de obstrução de condutos (grupo 2), e 1 pacientes recebeu ambos os dispositivos simultaneamente. A média de idade dos pacientes do grupo 1 no momento do procedimento era de 174 +- 53,5 meses e o peso médio era de 30,7 +- 6,8 kg. A média de idade dos pacientes do grupo 2 no momento do procedimento era de...


BACKGROUND: The introduction of total cavopulmonary anastomosis (TCPA) or Fontan procedure significantly changed the natural history of patients with complex heart diseases inadequate for biventricular repair. However, the development of silent stenosis is well known. In addition, fenestrated conduits are frequently used. The present study reports the experience of a tertiary center with percutaneous devices implanted in the conduits of patients with univentricular circulation. METHOD: From July 2000 to July 2010, 12 patients received percutaneous devices in conduits after Fontan procedure. Patients were divided into two groups, according to the indication for the procedure: 5 patients received septal occluders to close surgical fenestrations (group 1), 6 patients received stents for the relief of conduit obstructions (group 2) and 1 patient received both devices simultaneously. Mean age of group 1 patients at the time of the procedure was 174 ± 53.5 months and mean weight was 30.7 ± 6.8 kg. Mean age of group 2 patients was 148.5 ± 84.6 months and mean weight was 28.9 ± 19.8 kg. RESULTS: In group 1, oxygen saturation rose from 82.6 ± 7.5% to 90.4 ± 7.5% immediately after the procedure (P = 0.001). In group 2, oxygen saturation rose from 81.8 ± 8.9% to 91.3 ± 8.7% (P = 0.01). The minimal conduit diameter changed from 6.9 + 4,8 mm to 16.6 ± 3.5 mm after the procedure (P = 0.02). The patient who was submitted to both procedures simultaneously had an increase of the minimal conduit diameter from 11.7 mm to 16 mm and an improvement in systemic saturation from 60% to 90%. CONCLUSION: Treatment of conduit obstructions with non-covered stents and the occlusion of surgical fenestrations with covered stents or AmplatzerTM devices are safe procedures, with high immediate success rates which are maintained in the mid-term follow-up.


Subject(s)
Humans , Child , Prostheses and Implants , Heart Defects, Congenital/surgery , Stents , Echocardiography/methods , Echocardiography , Retrospective Studies
6.
Rev. bras. cir. cardiovasc ; 22(3): 367-368, jul.-set. 2007. ilus
Article in Portuguese | LILACS | ID: lil-466308

ABSTRACT

Dados Clínicos: Criança negra, sexo feminino e natural de Paulínia, SP. No quarto dia de vida, apresentou cianose de extremidades, recebendo prostaglandina e sendo encaminhada para nosso Serviço após diagnóstico de cardiopatia congênita. Neste momento, a radiografia lembrava área cardíaca com forma ovóide e eletrocardiograma com sobrecarga ventricular...


Subject(s)
Humans , Female , Child, Preschool , Child , Heart Defects, Congenital/surgery , Echocardiography
SELECTION OF CITATIONS
SEARCH DETAIL